Neurocrine Bioscience buy Raymond James
Start price
10.10.24
/
50%
€102.20
Target price
10.10.25
€141.69
Performance (%)
15.41%
End price
11.10.25
€117.95
Summary
This prediction ended on 11.10.25 with a price of €117.95. The prediction had a final performance of 15.41%. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | 4.005% | 4.005% | 0.589% |
| iShares Core DAX® | 1.085% | -1.655% | 13.297% |
| iShares Nasdaq 100 | -1.665% | -3.137% | 2.218% |
| iShares Nikkei 225® | 3.863% | 6.947% | 22.818% |
| iShares S&P 500 | 0.111% | -1.320% | 1.445% |
Comments by Raymond_James for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $155.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Raymond_James for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.50
01.11.23
01.11.23
€137.63
01.11.24
01.11.24
5.73%
02.11.24
02.11.24
